Eddy Hsueh, MD
Surgery · Saint Louis, MONPI 1003910225
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,688 of the $3,621 with a category attached, or 74.2%. Novartis accounts for 60.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $2,324 and has fallen 97.5% since, to $58 in 2025.
Across 15 payments — averaging $241.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Covidien LP$488
- Davol Inc.$433
- Regeneron Healthcare Solutions, Inc.$141
- Intuitive Surgical$138
- KCI USA, Inc.$124
- plus $98 from 2 others
Across 10 payments — averaging $1232.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$11K
- US Endoscopy$950
What the payments were for
- Consulting fees$2,68874%
- Food & beverage$93326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 1 | $2,200 |
| Covidien LP | 1 | $488 |
| Davol Inc. | 5 | $433 |
| Regeneron Healthcare Solutions, Inc. | 2 | $141 |
| Intuitive Surgical | 2 | $138 |
| KCI USA, Inc. | 2 | $124 |
| Iovance Biotherapeutics, Inc. | 1 | $58 |
| Alcresta Therapeutics, Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MEKINIST$2,200
- TAFINLAR$2,200
- LigaSure$488
- PHASIX$249
- LIBTAYO$123
- VAC VERAFLO$113
- Da Vinci Surgical System$100
How this compares
$3,621 in reported general payments places this provider in the 65th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 197 | $479 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $353 |
| Tramadol Hcl | 123 | $181 |
| Clindamycin Hcl | 48 | $138 |
Paid to pharmacies, not to this prescriber.
Other surgery in Saint Louis
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
- Sekhar DharmarajanSaint Louis$110K
- Shaina EckhouseSaint Louis$67K
- Jason RheeSaint Louis$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.